SecBot SecBot
COURT-RULING ·Filed Nov 2, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizonmonths Processed1d 1h ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

Monitor for the scope of documents produced and any subsequent summary judgment motions. The core FCA case remains unresolved; this ruling increases discovery burden but does not change the fundamental risk profile.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$973.36
T+0 close · Nov 3, 2026 · via day close
Latest settled
−4.39%
T+1 · $930.67
vs SPY
−6.04%
α at T+1
Next horizon
T+5
in 6d
  1. T+0 · Nov 3 $973.36entry
  2. T+1 · 11h ago −4.39%α −6.04% · $930.67
  3. T+5 · in 6d Pending
  4. T+20 · in 28d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The court granted in part the government's motion to compel in a False Claims Act case against Regeneron, finding that Regeneron impliedly waived attorney-client privilege over documents related to outside counsel's 2017 comment that classifying credit card fees as BFSFs was 'very questionable.' The ruling is interlocutory and procedural, it compels document production but does not resolve liability or damages.

Court Ruling Details

Ruling Date
Nov 2, 2026
Court
United States District Court for the District of Massachusetts
Court Level
District
Judge
Patti B. Saris
Case Type
other
Ruling Type
discovery
Outcome
PARTIAL: mixed ruling, some claims won/lost
Appeal Status
Interlocutory (case continues)
Precedent Risk
LOW

Key Facts

  • Court found Regeneron impliedly waived attorney-client privilege over communications related to outside counsel Stephanie Trunk's 2017 comment that classifying credit card fees as BFSFs was 'very questionable'.
  • Regeneron must produce documents and communications related to Trunk's comment forthwith.
  • No damages were awarded; no injunction was issued; the case remains pending.
  • The ruling is interlocutory and does not determine liability or the merits of the False Claims Act allegations.

Financial Impact

No damages awarded; the ruling compels document production only.

legal exposurelitigation costs

Risk Factors

  • The compelled documents could contain damaging admissions that strengthen the government's case.
  • Further privilege waivers may occur if Regeneron's good faith defense relies on counsel's advice at trial.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-38af13a779-REGN
48 reports for REGN
Performance horizon
63% Hit rate @ T+5 12 of 19 bullish or bearish reports Went positive at some point 17 of 20 best @ T+20▲ +31.76%Oct 6, 2026
Filters
Rows
Reports for REGN, sortable and filterable
TypeNow
Nov 4, 2026
today
144
NEUTRAL ★ 1/10
$931.06awaiting T+5awaiting T+5$930.67 (−0.04%)
Nov 4, 2026
today
144
NEUTRAL ★ 2/10
$930.67awaiting T+5awaiting T+5$930.67 (−0.00%)
Nov 3, 2026
1d ago
Insider Cluster
NEUTRAL ★ 2/10
$973.35awaiting T+5awaiting T+5$930.67 (−4.38%)
Nov 3, 2026
1d ago
144
NEUTRAL ★ 2/10
$971.00awaiting T+5awaiting T+5$930.67 (−4.15%)
Nov 3, 2026
1d ago
Insider Cluster
NEUTRAL ★ 2/10
$973.36awaiting T+5awaiting T+5$930.67 (−4.39%)
Nov 2, 2026
2d ago
144
NEUTRAL ★ 2/10
$973.36awaiting T+5awaiting T+5$930.67 (−4.39%)
Nov 2, 2026
2d ago
144
NEUTRAL ★ 2/10
$973.36awaiting T+5awaiting T+5$930.67 (−4.39%)
Nov 2, 2026
2d ago
144
NEUTRAL ★ 2/10
$973.36awaiting T+5awaiting T+5$930.67 (−4.39%)
Nov 2, 2026
2d ago
Court Ruling
NEUTRAL ★ 3/10
$973.36awaiting T+5awaiting T+5$930.67 (−4.39%)
Oct 30, 2026
5d ago
144
NEUTRAL ★ 2/10
$961.26awaiting T+5awaiting T+5$930.67 (−3.18%)
Showing 10 of 48

US Market Status

Market Closed · Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Nov 3, 2026